Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Short‐term mortality · people with necrotising pancreatitis Interventions for necrotising pancreatitis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Organ failure · people with necrotising pancreatitis Interventions for necrotising pancreatitis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events (number) · people with necrotising pancreatitis Interventions for necrotising pancreatitis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Short‐term mortality · patients with pancreatic pseudocysts Management strategies for pancreatic pseudocysts (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Hospital stay · patients with pancreatic pseudocysts Management strategies for pancreatic pseudocysts (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · patients with pancreatic pseudocysts Management strategies for pancreatic pseudocysts (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Serious adverse events · patients with pancreatic pseudocysts Management strategies for pancreatic pseudocysts (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · patients with pancreatic pseudocysts Management strategies for pancreatic pseudocysts (2016) · Cochrane | no estimate extracted | NR | No studies |
Very early cerebral revascularization vs delayed treatment Lenght of hospital stay · people with recently symptomatic carotid artery stenosis Immediate versus delayed treatment for recently symptomatic carotid artery stenosis (2016) · Cochrane | no estimate extracted | NR | No studies |
Very early cerebral revascularization vs delayed treatment Myocardial infarction < 30 days · people with recently symptomatic carotid artery stenosis Immediate versus delayed treatment for recently symptomatic carotid artery stenosis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Participants with at least one adverse event · adults with acute postoperative pain Single dose dipyrone (metamizole) for acute postoperative pain in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs antiseptic Wounds healed 5‐14 days · people presenting for surgery where healing of surgical wound planned to be by primary intention Topical antibiotics for preventing surgical site infection in wounds healing by primary intention (2016) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs no topical antibiotic. Anaphylaxis · people presenting for surgery where healing of surgical wound(s) was planned to be by primary intention Topical antibiotics for preventing surgical site infection in wounds healing by primary intention (2016) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs no topical antibiotic. Patterns of antibiotic resistance · people presenting for surgery where healing of surgical wound(s) was planned to be by primary intention Topical antibiotics for preventing surgical site infection in wounds healing by primary intention (2016) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs no topical antibiotic. Wounds healed 5‐14 days · people presenting for surgery where healing of surgical wound(s) was planned to be by primary intention Topical antibiotics for preventing surgical site infection in wounds healing by primary intention (2016) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs antiseptic Anaphylaxis · people presenting for surgery where healing of surgical wound planned to be by primary intention Topical antibiotics for preventing surgical site infection in wounds healing by primary intention (2016) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs antiseptic Patterns of antibiotic resistance · people presenting for surgery where healing of surgical wound planned to be by primary intention Topical antibiotics for preventing surgical site infection in wounds healing by primary intention (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cumulative pain score from the end of operation (0 hours) to 72 hours · adults aged ≥ 18 years undergoing elective surgery at any surgical site Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Time to first postoperative opioid dose · adults aged ≥ 18 years undergoing elective surgery at any surgical site Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Percentage of participants not requiring postoperative opioids over initial 72 hours · adults aged ≥ 18 years undergoing elective surgery at any surgical site Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health economic assessment · adults aged ≥ 18 years undergoing elective surgery at any surgical site Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of adverse events within 30 days of surgery · adults aged ≥ 18 years undergoing elective surgery at any surgical site Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient‐reported outcomes · adults aged ≥ 18 years undergoing elective surgery at any surgical site Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (2016) · Cochrane | no estimate extracted | NR | No studies |
Duodenum‐preserving pancreatic resection vs pancreaticoduodenectomy Serious adverse events · people requiring surgery for chronic pancreatitis Duodenum‐preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis (2016) · Cochrane | no estimate extracted | NR | No studies |
Therapist‐supported ICBT vs face‐to‐face CBT Adverse events at post‐treatment ‐ not reported · adults with anxiety disorders Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Clinical improvement in pulse rate · adults with schizophrenia or related disorders treated for clozapine‐induced tachycardia Pharmacological interventions for clozapine‐induced sinus tachycardia (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Improvement in heart rate · adults with schizophrenia or related disorders treated for clozapine‐induced tachycardia Pharmacological interventions for clozapine‐induced sinus tachycardia (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Duration of hospitalisation · adults with schizophrenia or related disorders treated for clozapine‐induced tachycardia Pharmacological interventions for clozapine‐induced sinus tachycardia (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Clinically important adverse events · adults with schizophrenia or related disorders treated for clozapine‐induced tachycardia Pharmacological interventions for clozapine‐induced sinus tachycardia (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient satisfaction · adults with schizophrenia or related disorders treated for clozapine‐induced tachycardia Pharmacological interventions for clozapine‐induced sinus tachycardia (2016) · Cochrane | no estimate extracted | NR | No studies |
Hydroxyurea vs placebo or standard care Frequency of transfusion · people with non‐transfusion dependent beta thalassaemia Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias (2016) · Cochrane | no estimate extracted | NR | No studies |
Hydroxyurea vs placebo or standard care Major adverse effects · people with non‐transfusion dependent beta thalassaemia Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias (2016) · Cochrane | no estimate extracted | NR | No studies |
Hydroxyurea vs placebo or standard care Quality of life · people with non‐transfusion dependent beta thalassaemia Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias (2016) · Cochrane | no estimate extracted | NR | No studies |
Hydroxyurea vs placebo or standard care Mean Hb F (g/dL) · people with non‐transfusion dependent beta thalassaemia Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Frequency of transfusion · people with non‐transfusion dependent beta thalassaemia Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · people with non‐transfusion dependent beta thalassaemia Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias (2016) · Cochrane | no estimate extracted | NR | No studies |
Oral hydromorphone vs placebo Substantial benefit: ≥ 50% reduction in pain PGIC much improved · adults with chronic neuropathic pain Hydromorphone for neuropathic pain in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Oral hydromorphone vs placebo Moderate benefit: ≥ 30% reduction in pain PGIC much or very much improved · adults with chronic neuropathic pain Hydromorphone for neuropathic pain in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Oral hydromorphone vs placebo Serious adverse events · adults with chronic neuropathic pain Hydromorphone for neuropathic pain in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Oral hydromorphone vs placebo Deaths · adults with chronic neuropathic pain Hydromorphone for neuropathic pain in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Substantial benefit: at least 50% reduction in pain, or PGIC much improved · Adults with chronic neuropathic pain Fentanyl for neuropathic pain in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Amnioinfusion vs no amnioinfusion Perinatal death or severe morbidity (neonatal encephalopathy, intraventricular haemorrhage, admission to intensive/high care) · pregnant women with confirmed or suspected chorioamnionitis Amnioinfusion for chorioamnionitis (2016) · Cochrane | no estimate extracted | NR | No studies |
Amnioinfusion vs no amnioinfusion Low Apgar score at five minutes (less than seven or as defined by trial authors) · pregnant women with confirmed or suspected chorioamnionitis Amnioinfusion for chorioamnionitis (2016) · Cochrane | no estimate extracted | NR | No studies |
Any skin care procedure (method or frequency of application) vs any unstructured skin care procedure Number of participants with IAD (new) · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Any skin care procedure (method or frequency of application) vs any unstructured skin care procedure Number of participants not satisfied with treatment · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Any skin care procedure (method or frequency of application) vs any unstructured skin care procedure Number of participants with pain due to IAD · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Any skin care procedure (method or frequency of application) vs any unstructured skin care procedure Number of participants with pain due to skin care product or procedure · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Any skin care procedure (method or frequency of application) vs any unstructured skin care procedure Adverse reaction due to the skin care product or procedure, e.g. skin irritation, rash, itching, allergic reaction · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Any skin care procedure (method or frequency of application) vs any unstructured skin care procedure Incremental cost‐effectiveness · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Any method of application of a topical skin care product vs another method of application of the topical skin care product Number of participants with IAD (residual, i.e. not healed) · adults with incontinence Interventions for preventing and treating incontinence‐associated dermatitis in adults (2016) · Cochrane | no estimate extracted | NR | No studies |